Cardiol Therapeutics
$2.3
1
+$0.12+5.5% Monday 19:54
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
98.78M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
30JunExpected
Expected EPS
-0.14
Actual EPS
-0.1321
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CRTPF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmaceuticals: Major
Health Technology
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Show more...
CEO
David G. Elsley
Country
CA
ISIN
CA14161Y2006
Listings
0 Comments
Share your thoughts
FAQ
What is Cardiol Therapeutics stock price today?▼
The current price of CRTPF is $2.3 USD — it has increased by +5.5% in the past 24 hours. Watch Cardiol Therapeutics stock price performance more closely on the chart.
What is Cardiol Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardiol Therapeutics stocks are traded under the ticker CRTPF.
What is Cardiol Therapeutics market cap?▼
Today Cardiol Therapeutics has the market capitalization of 98.78M
What were Cardiol Therapeutics earnings last quarter?▼
CRTPF earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.14 USD resulting in a +5.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Cardiol Therapeutics located?▼
Cardiol Therapeutics operates in the Healthcare sector.
When did Cardiol Therapeutics complete a stock split?▼
Cardiol Therapeutics has not had any recent stock splits.
Where is Cardiol Therapeutics headquartered?▼
Cardiol Therapeutics is headquartered in Oakville, CA.